Lakefront Biotherapeutics NV 20-F for FY2023
Lakefront Biotherapeutics NV (LKFT)
20-F
2024-03-28
For: 2023-12-31
View Original
Added on
April 04, 2026
About this 20-F
Lakefront Biotherapeutics NV filed this 20-F on March 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 239.72M EUR
- down 0.6% from 241.25M EUR a year earlier
- Net income
- 211.7M EUR
- compared with a net loss of 217.99M EUR a year earlier
- Diluted EPS
- 3.21 EUR
- compared with -3.32 EUR a year earlier